UDG Healthcare Public Limited Co. Notice of Full Year Results (1013E)

TIDMUDG

RNS Number : 1013E

UDG Healthcare Public Limited Co.

03 November 2020

UDG Healthcare plc

Notice of Full Year Results

UDG Healthcare plc (LSE: UDG), a leading international healthcare services provider, will be announcing its full year results for year ended 30 September 2020 on the morning of Tuesday 24 November 2020.

Brendan McAtamney, Chief Executive Officer, Nigel Clerkin, Chief Financial Officer, and Ryan Quigley, Chief Operating Officer will host a presentation for analysts and investors to discuss the company's full year results and provide an update on each of the Group's divisions, followed by a Q&A.

 
 Date:                 Tuesday 24 November 2020 
 Presentation times:   Results presentation will be available to 
                        watch on demand from 7.00am, via a pre-recorded 
                        video webcast 
                        https://secure.emincote.com/client/udghealthcare/udg006 
                       Live Q&A will commence at 9.00am, available 
                        via audio webcast and conference call. 
 
                        Q&A conference call registration link: 
                        https://secure.emincote.com/client/udghealthcare/udg005/vip_connect 
                       Q&A webcast registration link: 
                        https://secure.emincote.com/client/udghealthcare/udg005 
 

Please note: If you wish to ask a question during the live Q&A at 9.00am, please dial into the conference call, as participants on the webcast will be in listen-only mode and therefore unable to ask questions.

It is suggested participants dial-in to the Q&A at least 15 minutes prior in order to ensure a timely start to the briefing.

For further information, please contact:

 
 UDG Healthcare plc 
  Keith Byrne 
 Head of Investor Relations, Strategy & Corporate 
  Communications 
 Tel: [phone] 
 
 Powerscourt 
 Lisa Kavanagh / Jack Hickey / Eavan Gannon 
  / Ella Morris 
 [e-mail] 
 

About UDG Healthcare plc:

UDG Healthcare plc (LON: UDG) is a FTSE 250 global leader in the healthcare advisory, communications, commercial, clinical and packaging services industries. UDG employs 9,000 people across operations in 29 countries, delivering services in over 50 countries.

Operating across two divisions, Ashfield and Sharp, UDG provides outsourced services which enable over 300 healthcare companies from large pharmaceutical to small biotech to bring their products to market.

Ashfield is a global leader in commercialisation services for the pharmaceutical and healthcare industry, operating across three business areas: Advisory, Communications and Commercial & Clinical. The division focuses on supporting patients to access and adhere to their medications and educating and communicating effectively with healthcare professionals and patients on these products at all stages of the product life cycle. Ashfield provides strategic consulting, advisory services, patient solutions, scientific and creative communications, PR, on-demand advertising services, field and contact centre sales teams, and medical information and event management services.

Sharp is a global leader in contract commercial packaging, clinical, manufacturing and technology services for the pharmaceutical and biotechnology industries, operating from eight state-of-the-art facilities in the US and Europe.

For more information, please go to: www.udghealthcare.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

NORFXLFBBFLBFBV

(END) Dow Jones Newswires

November 03, 2020 06:15 ET (11:15 GMT)